Global Medical REIT Inc. (NYSE: GMRE) Expected to Post Quarterly Sales of $30.64 Million

Wall Street analysts predict that Global Medical REIT Inc. (NYSE:GMRE – Get a rating) will announce sales of $30.64 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have released earnings estimates for Global Medical REIT, with the lowest sales estimate at $29.88 million and the highest estimate at $31.34 million. Global Medical REIT reported sales of $27.35 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 12%. The company is due to release its next results on Monday, January 1.

On average, analysts expect Global Medical REIT to report annual revenue of $125.57 million for the current fiscal year, with estimates ranging from $119.76 million to $132.84 millions of dollars. For the next fiscal year, analysts expect the company to report sales of $133.68 million, with estimates ranging from $120.21 million to $152.54 million. Zacks sales calculations are an average average based on a survey of analysts who cover Global Medical REIT.

Global Medical REIT (NYSE: GMRE – Get a rating) last reported quarterly earnings data on Monday, February 28. The company reported earnings per share of $0.06 for the quarter, missing Thomson Reuters consensus estimate of $0.23 per ($0.17). Global Medical REIT posted a net margin of 15.20% and a return on equity of 3.20%. During the same period last year, the company posted earnings per share of $0.24.

(A d)

Small cap stocks – and penny stocks in particular – tend to march to the beat of their own beater.

Low-priced penny stocks like these offer a great way to make money regardless of the direction of the markets as a whole…

Click here to see how you can get the names and stock symbols of the four penny stocks.

Several equity research analysts have recently commented on GMRE shares. StockNews.com began covering Global Medical REIT in a report on Thursday. They set a “hold” rating for the company. B. Riley cut his target price on Global Medical REIT from $20.00 to $18.00 in a Wednesday, March 2 report. Ultimately, Zacks Investment Research upgraded Global Medical REIT from a “Strong Sell” rating to a “Hold” rating in a report on Tuesday, February 8. Two equity research analysts gave the stock a hold rating and four gave the company a buy rating. Based on MarketBeat data, Global Medical REIT has an average rating of “Buy” and a consensus price target of $17.20.

In related news, CEO Jeffrey Busch acquired 2,000 shares in a transaction dated Thursday, March 3. The shares were acquired at an average price of $15.55 per share, with a total value of $31,100.00. The purchase was disclosed in a filing with the SEC, accessible via this hyperlink. Company insiders hold 7.60% of the company’s stock.

A number of large investors have recently changed their positions in GMRE. Barclays PLC raised its position in shares of Global Medical REIT by 160.6% in the fourth quarter. Barclays PLC now owns 75,992 shares in the company worth $1,349,000 after acquiring an additional 46,829 shares during the period. BlackRock Inc. increased its position in shares of Global Medical REIT by 1.8% in the fourth quarter. BlackRock Inc. now owns 4,863,718 shares of the company worth $86,332,000 after acquiring an additional 84,517 shares during the period. Toroso Investments LLC purchased a new stake in shares of Global Medical REIT in Q4 for a value of approximately $231,000. ETF Store Inc. purchased a new stake in shares of Global Medical REIT in Q4 for a value of approximately $192,000. Finally, California State Teachers Retirement System increased its position in shares of Global Medical REIT by 6.0% in the 4th quarter. California State Teachers Retirement System now owns 83,876 shares of the company worth $1,489,000 after acquiring 4,751 additional shares during the period. Hedge funds and other institutional investors own 70.85% of the company’s shares.

Shares of Global Medical REIT opened at $16.32 on Friday. The company has a quick ratio of 0.19, a current ratio of 0.19 and a leverage ratio of 0.92. The company has a market cap of $1.07 billion, a price-to-earnings ratio of 85.90, a growth price-to-earnings ratio of 2.05, and a beta of 0.87. The company has a fifty-day simple moving average of $16.05 and a 200-day simple moving average of $16.28. Global Medical REIT has a fifty-two week minimum of $12.85 and a fifty-two week maximum of $18.51.

The company also recently announced a quarterly dividend, which will be paid on Friday, April 8. Shareholders of record on Friday, March 25 will receive a dividend of $0.21. This is a positive change from Global Medical REIT’s previous quarterly dividend of $0.21. This represents an annualized dividend of $0.84 and a yield of 5.15%. The ex-date of this dividend is Thursday, March 24. Global Medical REIT’s dividend payout ratio is currently 442.13%.

About Global Medical REIT (Get a rating)

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and the leasing of these properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is based in Bethesda, MD.

Featured articles

Get a Free Copy of Zacks Research Report on Global Medical REIT (GMRE)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

Earnings history and estimates for Global Medical REIT (NYSE:GMRE)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Global Medical REIT right now?

Before you consider Global Medical REIT, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes hold…and Global Medical REIT was not on the list.

While Global Medical REIT currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Comments are closed.